Companies: 10,795·Total market cap: $144.5T
Sanofi

Sanofi

SNYNASDAQHealthcare● Active
$43.88
$-1.14(-2.53%)
Market Cap$105.7B
P/E Ratio
52W High$52.68
52W Low$42.28
Overview

Sanofi (SNY) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · SNY · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income$5.57B$5.50B$5.40B$8.37B$6.22B
Depreciation & Amort.$6.46B$3.59B$3.78B$3.42B$3.35B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.24B$0.24B
Change in Working Capital$2.03B($0.61B)$0.76B($0.71B)$1.41B
Net Cash from Operations$12.13B$9.08B$10.26B$10.53B$10.52B
Investing Activities
Capital Expenditure($1.99B)($3.19B)($1.62B)($2.20B)($2.04B)
Purchases of Investments($11.37B)$0.00B($0.13B)($0.49B)($0.31B)
Sales of Investments$0.00B$0.00B$0.04B$0.00B$0.72B
Net Cash from Investing($2.76B)($4.41B)($6.20B)($2.08B)($7.30B)
Financing Activities
Common Stock Repurchased($5.68B)($0.30B)($0.59B)($0.50B)($0.38B)
Dividends Paid($5.39B)($4.70B)($4.45B)($4.17B)($4.01B)
Debt Issued / Repaid$2.07B($0.89B)($3.14B)($1.23B)($2.80B)
Net Cash from Financing($9.26B)($5.76B)($8.05B)($5.82B)($7.06B)
Free Cash Flow
Free Cash Flow$10.14B$5.89B$8.64B$8.32B$8.48B
FCF Margin %(computed)21.71%13.29%20.76%20.52%21.64%

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · EUR · B

Explore more Sanofi data

About Sanofi (SNY) Cash Flow Statement

Sanofi generated operating cash flow of $12.13B and free cash flow of $10.14B for 2025 — a FCF margin of 21.71%. Capital expenditure was ($1.99B).

Frequently asked questions

SNY · 4 questions

Sanofi generated free cash flow of $10.14B for 2025, up 72.3% year-over-year.

SNY free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10